<DOC>
	<DOCNO>NCT02170506</DOCNO>
	<brief_summary>Swallowing complex phenomenon allow oral feed protect airway . It involve many brain area , include primary motor sensory area . Its dysfunction , call oropharyngeal dysphagia present approximately 60 % patient stroke . In case , conventionally translate swallow response time delay swallow reflex . Pathophysiology dysphagia explain impairment dominant swallowing , function representation center bi-hemispheric asymmetric ( Hamdy , 1997 ) . Half patient stroke supra-tentoriel oropharyngeal dysphagia ( 55 % stroke ) regain normal swallowing week ( Barer , 1989 ) . Mechanisms determine recovery appear relate reorganization motor cortex intact . Patients retain disorder cortical reorganization . With mind team use different method know modulate brain plasticity , electrotherapy application endo- pharyngeal sensory threshold . This stimulation increase excitability cortico- bulbar reflex , improve swallow function clinical application . The hypothesis work transcutaneous electrical stimulation apply submental , noninvasive technique , would also impact cortical plasticity may explain improved coordination swallow observe early study ( Verin , 2011 ) ( Gallas , 2010 ) .</brief_summary>
	<brief_title>Effect Sub-mental Sensitive Transcutaneous Electrical Stimulation Pharyngeal Muscles Control : TENSVIRT Study</brief_title>
	<detailed_description />
	<mesh_term>Deglutition Disorders</mesh_term>
	<criteria>1 . Subjects age 18 year 2 . Affilitation social security scheme 3 . Registration National register people participate biomedical research 4 . Healthy volunteer provide write informed consent 1 . Subjects swallow disorder 2 . Presence psychiatric disorder 3 . Skin disorder 4 . Cardiac disorder ( non control arrythmia , severe heart failure , presence heart valve ) 5 . Submental tumor 6 . Epilepsia , treat untreated 7 . Presence neurosurgical clip 8 . Suspicion digestive fistula 9 . Presence metal , pacemaker , defibrillator , pump treatment neurostimulation 10 . Cannabis user , regular use benzodiazepine 11 . Presence chronic respiratory , neurological disease , ENT gastroesophageal disease ( cause potentially change swallow ) 12 . Contraindication MRI ( claustrophobia , metal fragment , cardiac/ENT/neurological implantable device MRI compatible , osteosynthesis prior 1980 ) 13 . Subject report use MicropaqueÂ® 14 . Pregnant nursing woman , absence contraception 15 . Poor understanding French langage 16 . Person judicial protection 17 . Person deprive liberty judicial administrative decision 18 . Participating clinical trial within 4 week preinclusion visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>